Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Rockwell Medical
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Dialysis Demand Will Grow Despite Margin And Market Challenges
Key Takeaways Increased demand for dialysis solutions and successful long-term contracts drive stable growth and revenue visibility, especially as the company enters new and underserved markets. Operational improvements and a strong reputation enhance margins and market share, with expanded access and customer acquisitions supporting further revenue gains.
View narrative
US$4.00
FV
71.5% undervalued
intrinsic discount
-6.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
9 days ago
author updated this narrative
Clearside Biomedical
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
FDA Alignment And Phase 3 Trials Will Advance AMD Therapy
Key Takeaways FDA alignment on CLS-AX for wet AMD and Phase 2b outcomes may boost revenues and market leadership upon approval. Global partnerships and SCS technology expansions could enhance international market presence and revenue streams.
View narrative
US$4.00
FV
89.8% undervalued
intrinsic discount
38.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
Laird Superfood
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Retail Expansion And Clean Label Trends Will Support Future Value
Key Takeaways Expanding retail distribution and ongoing product innovation position the company to diversify revenues, tap into new markets, and meet rising demand for functional, clean-label foods. Operational improvements, cost discipline, and a strong balance sheet reduce financial risk, supporting sustained gross margins and enabling long-term growth investments.
View narrative
US$12.67
FV
53.0% undervalued
intrinsic discount
20.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
Senzime
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US And European Guidelines Will Expand Neuromuscular Monitoring Adoption Worldwide
Key Takeaways Adoption driven by regulatory changes and expansion into new patient segments supports scalable, predictable growth and strengthens market position globally. Product innovation and recurring revenue streams improve margins, offsetting economic headwinds and enhancing long-term earnings stability.
View narrative
SEK 12.80
FV
48.0% undervalued
intrinsic discount
81.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
P3 Health Partners
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US Healthcare Operational Improvements Will Pave Path To Profitability
Key Takeaways Strategic initiatives in operational efficiencies, contracting, and execution aim to significantly boost EBITDA, net margins, and earnings. Innovative programs and strategic partnerships enhance service offerings and revenue predictability, supporting long-term profitability and growth.
View narrative
US$8.00
FV
10.1% undervalued
intrinsic discount
2.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
Neuronetics
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Expanding Mental Healthcare Outreach Will Unlock Future Potential
Key Takeaways Strategic provider programs and operational improvements are enhancing patient conversion, driving higher procedure volumes, and improving operating margins. Expansion into adolescent care and broader market acceptance are creating new revenue streams, supporting sustained multi-year growth and brand differentiation.
View narrative
US$6.50
FV
47.7% undervalued
intrinsic discount
21.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
EDAP TMS
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
CE Mark And Global Expansion Will Elevate HIFU Adoption
Key Takeaways New approvals and strategic collaborations enhance EDAP TMS's market opportunities, potentially driving future revenue growth and improving margins. Expanded market presence through international and U.S. expansions may lead to increased utilization and revenue from Focal One.
View narrative
US$5.75
FV
76.5% undervalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
Sportsman's Warehouse Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Hunting And Fishing Focus And Omnichannel Retail Will Boost Efficiency
Key Takeaways Focus on core strengths in hunting and fishing, improved inventory, and local strategies are expected to drive revenue growth and enhance margins. Emphasis on omnichannel retail, e-commerce improvements, and personal protection expansion could boost sales, diversify revenue, and enhance customer experiences.
View narrative
US$3.45
FV
15.7% undervalued
intrinsic discount
1.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
9 days ago
author updated this narrative
Calix
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Hybrid Energy And US Water Projects Will Define Future Efficiency
Key Takeaways Advancements in electrification technology could reduce operational costs and improve net margins through lower fossil fuel dependency. Restructuring and reduced headcount aim to enhance profitability, while strong revenue growth and strategic collaborations promise future revenue increases.
View narrative
AU$1.70
FV
73.8% undervalued
intrinsic discount
33.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies